Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker RVPH
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 13, 2026 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 13, 2026 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 12, 2026 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 12, 2026 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 13, 2026 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 13, 2026 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 13, 2026 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 13, 2026 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Apr 15, 2026 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Apr 15, 2026 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 30, 2026 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 30, 2026 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 19, 2026 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 19, 2026 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 5, 2026 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 5, 2026 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Mar 5, 2026 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 3.03 Material Modification to Rights of Security Holders | 8-K | 8-K ↗ |
| Jan 23, 2026 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 23, 2026 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Dec 23, 2025 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 23, 2025 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 23, 2025 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Dec 23, 2025 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Nov 13, 2025 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 13, 2025 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 17, 2025 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Sep 26, 2025 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Sep 19, 2025 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 19, 2025 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 14, 2025 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 14, 2025 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 26, 2025 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 26, 2025 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 6, 2025 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 4.01 Changes in Registrant's Certifying Accountant | 8-K | 8-K ↗ |
| Jun 2, 2025 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 2, 2025 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 30, 2025 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 15, 2025 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 15, 2025 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 31, 2025 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 31, 2025 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 18, 2025 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Dec 18, 2024 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 18, 2024 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 16, 2024 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 16, 2024 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Dec 12, 2024 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Dec 12, 2024 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Nov 14, 2024 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 14, 2024 | RVPH Reviva Pharmaceuticals Holdings, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 16, 2026, 8:19 AM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances